Analysis of the Fibrinogen and Neutrophil–Lymphocyte Ratio in Esophageal Squamous Cell Carcinoma: A Promising Blood Marker of Tumor Progression and Prognosis

Esophageal squamous cell carcinoma (ESCC) is one of the most aggressive malignancies in gastrointestinal tract cancers and even patients with early ESCC have a high metastatic potential. Difficulties are associated with clinically predicting tumor progression and prognosis based on conventional tumo...

Full description

Bibliographic Details
Main Authors:	Arigami, Takaaki, Okumura, Hiroshi, Matsumoto, Masataka, Uchikado, Yasuto, Uenosono, Yoshikazu, Kita, Yoshiaki, Owaki, Tetsuhiro, Mori, Shinichiro, Kurahara, Hiroshi, Kijima, Yuko, Ishigami, Sumiya, Natsugoe, Shoji
Format:	Online
Language:	English
Published:	Wolters Kluwer Health 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620830/

id	pubmed-4620830
recordtype	oai_dc
spelling	pubmed-46208302015-10-27 Analysis of the Fibrinogen and Neutrophil–Lymphocyte Ratio in Esophageal Squamous Cell Carcinoma: A Promising Blood Marker of Tumor Progression and Prognosis Arigami, Takaaki Okumura, Hiroshi Matsumoto, Masataka Uchikado, Yasuto Uenosono, Yoshikazu Kita, Yoshiaki Owaki, Tetsuhiro Mori, Shinichiro Kurahara, Hiroshi Kijima, Yuko Ishigami, Sumiya Natsugoe, Shoji 4500 Esophageal squamous cell carcinoma (ESCC) is one of the most aggressive malignancies in gastrointestinal tract cancers and even patients with early ESCC have a high metastatic potential. Difficulties are associated with clinically predicting tumor progression and prognosis based on conventional tumor markers determined from preoperative blood examinations. The aim of the present study was to measure plasma fibrinogen levels and the neutrophil–lymphocyte ratio (NLR) in blood and compare the clinical impacts of their combined values (fibrinogen and neutrophil–lymphocyte ratio score—F-NLR score) and the modified Glasgow Prognostic Score (mGPS) in patients with ESCC. Wolters Kluwer Health 2015-10-23 /pmc/articles/PMC4620830/ /pubmed/26496280 http://dx.doi.org/10.1097/MD.0000000000001702 Text en Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
repository_type	Open Access Journal
institution_category	Foreign Institution
institution	US National Center for Biotechnology Information
building	NCBI PubMed
collection	Online Access
language	English
format	Online
author	Arigami, Takaaki Okumura, Hiroshi Matsumoto, Masataka Uchikado, Yasuto Uenosono, Yoshikazu Kita, Yoshiaki Owaki, Tetsuhiro Mori, Shinichiro Kurahara, Hiroshi Kijima, Yuko Ishigami, Sumiya Natsugoe, Shoji
spellingShingle	Arigami, Takaaki Okumura, Hiroshi Matsumoto, Masataka Uchikado, Yasuto Uenosono, Yoshikazu Kita, Yoshiaki Owaki, Tetsuhiro Mori, Shinichiro Kurahara, Hiroshi Kijima, Yuko Ishigami, Sumiya Natsugoe, Shoji Analysis of the Fibrinogen and Neutrophil–Lymphocyte Ratio in Esophageal Squamous Cell Carcinoma: A Promising Blood Marker of Tumor Progression and Prognosis
author_facet	Arigami, Takaaki Okumura, Hiroshi Matsumoto, Masataka Uchikado, Yasuto Uenosono, Yoshikazu Kita, Yoshiaki Owaki, Tetsuhiro Mori, Shinichiro Kurahara, Hiroshi Kijima, Yuko Ishigami, Sumiya Natsugoe, Shoji
author_sort	Arigami, Takaaki
title	Analysis of the Fibrinogen and Neutrophil–Lymphocyte Ratio in Esophageal Squamous Cell Carcinoma: A Promising Blood Marker of Tumor Progression and Prognosis
title_short	Analysis of the Fibrinogen and Neutrophil–Lymphocyte Ratio in Esophageal Squamous Cell Carcinoma: A Promising Blood Marker of Tumor Progression and Prognosis
title_full	Analysis of the Fibrinogen and Neutrophil–Lymphocyte Ratio in Esophageal Squamous Cell Carcinoma: A Promising Blood Marker of Tumor Progression and Prognosis
title_fullStr	Analysis of the Fibrinogen and Neutrophil–Lymphocyte Ratio in Esophageal Squamous Cell Carcinoma: A Promising Blood Marker of Tumor Progression and Prognosis
title_full_unstemmed	Analysis of the Fibrinogen and Neutrophil–Lymphocyte Ratio in Esophageal Squamous Cell Carcinoma: A Promising Blood Marker of Tumor Progression and Prognosis
title_sort	analysis of the fibrinogen and neutrophil–lymphocyte ratio in esophageal squamous cell carcinoma: a promising blood marker of tumor progression and prognosis
description	Esophageal squamous cell carcinoma (ESCC) is one of the most aggressive malignancies in gastrointestinal tract cancers and even patients with early ESCC have a high metastatic potential. Difficulties are associated with clinically predicting tumor progression and prognosis based on conventional tumor markers determined from preoperative blood examinations. The aim of the present study was to measure plasma fibrinogen levels and the neutrophil–lymphocyte ratio (NLR) in blood and compare the clinical impacts of their combined values (fibrinogen and neutrophil–lymphocyte ratio score—F-NLR score) and the modified Glasgow Prognostic Score (mGPS) in patients with ESCC.
publisher	Wolters Kluwer Health
publishDate	2015
url	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620830/
_version_	1613493202262687744

Analysis of the Fibrinogen and Neutrophil–Lymphocyte Ratio in Esophageal Squamous Cell Carcinoma: A Promising Blood Marker of Tumor Progression and Prognosis

Similar Items